Premature Onset of Cardiovascular Disease in HIV-Infected Individuals: The Drugs and the Virus

This publication has 240 references indexed in Scilit:

• Antiretroviral compounds and cholesterol efflux from macrophages
  Atherosclerosis, 2009
• Lipid Management in Patients Who Have HIV and Are Receiving HIV Therapy
  Endocrinology and Metabolism Clinics of North America, 2009
• Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality
  JAMA, 2008
• Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
  The Lancet, 2008
• Severe Impairment of Endothelial Function with the HIV-1 Protease Inhibitor Indinavir is not Mediated by Insulin Resistance in Healthy Subjects
  Cardiovascular Toxicology, 2008
• Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women
  JAMA, 2007
• Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
  JAMA, 2007
• Microbial translocation is a cause of systemic immune activation in chronic HIV infection
  Nature Medicine, 2006
• Inflammation, Atherosclerosis, and Coronary Artery Disease
  New England Journal of Medicine, 2005
• Interactions between commensal intestinal bacteria and the immune system
  Nature Reviews Immunology, 2004